Clinical trial
Evaluation of the Occurence of Thrombotic and Bleeding Events After Coronary Angioplasty With Stent According to Aspirin and Clopidogrel Platelet Reactivity Assessed by a Point of Care Assay in the Cathlab (the Verifynow French Registry)
NCT00753753 is registered in ClinicalTrials.gov with Association Pour le Développement des Soins Cardiologiques de la ville de Chartres as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Occurence of Thrombotic and Bleeding Events After Coronary Angioplasty With Stent According to Aspirin and Clopidogrel Platelet Reactivity Assessed by a Point of Care Assay in the Cathlab (the Verifynow French Registry)
- Lead sponsor
- Association Pour le Développement des Soins Cardiologiques de la ville de Chartres
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2008
- Completion date
- November 30, 2009
- Enrollment
- 1,001 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
angioplasty, aspirin, bleeding, clopidogrel, stent thrombosis